Skip to Content


In the US, Ticlopidine (ticlopidine systemic) is a member of the drug class platelet aggregation inhibitors and is used to treat Cerebral Thrombosis/Embolism.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiplatelet agent inhibiting adenosine diphosphate-mediated platelet aggregation

Chemical Name

tieno[3,2-c]pyridine, 5-[(2-chlorophenyl)metyl]-4,5,6,7-tetrahydro-

Foreign Names

  • Ticlopidinum (Latin)
  • Ticlopidin (German)
  • Ticlopidine (French)
  • Ticlopidina (Spanish)

Generic Names

  • Ticlopidina (OS: DCIT)
  • Ticlopidine (OS: DCF, BAN)
  • 4-C-32 (IS)
  • Ticlopidine Hydrochloride (OS: BANM, JAN, USAN)
  • 53-32 C (IS)
  • Ticlopidine (chlorhydrate de) (PH: Ph. Eur. 8)
  • Ticlopidine Hydrochloride (PH: BP 2015, JP XVI, USP 37)
  • Ticlopidine hydrochloride (PH: Ph. Eur. 8)
  • Ticlopidinhydrochlorid (PH: Ph. Eur. 8)
  • Ticlopidini hydrochloridum (PH: Ph. Eur. 8)

Brand Names

International Drug Name Search


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.